Dag L.
- Country
- Sweden
- Department
- Clinical Research and Development Unit,KFUE Dep.Of Oncology,Hematology and Endocrine CancersEntrance
Research Overview
- Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
- Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial
- Evaluation of FT819 in the Treatment of B-cell Mediated Autoimmune Diseases
Data & Insights
Has run more than one trial at 21 of 55 partner sites.
Specializations
Autoimmune Disease Management
This investigator specializes in studying therapeutic approaches for systemic lupus erythematosus (SLE), focusing on novel treatment strategies for patients with active disease manifestations.
- Chronic autoimmune conditions
- Disease activity management
- Long-term therapeutic outcomes
The investigator explores innovative therapeutic agents while considering standard of care approaches in autoimmune disease treatment.
Immunological Research
Their research centers on investigating targeted immunological therapies, particularly examining the role of novel biological agents in managing complex autoimmune disorders.
- Immune system modulation
- Biological therapy assessment
- Treatment response evaluation
The investigator's work encompasses continuous monitoring of immunological interventions and their impact on disease progression.
Clinical Safety Assessment
A key focus area includes evaluating the safety and tolerability profiles of emerging therapeutic agents in patients with autoimmune conditions.
- Long-term safety monitoring
- Treatment tolerability assessment
- Risk-benefit evaluation
The research incorporates comprehensive safety assessments alongside efficacy measurements in therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.